Objective: To compare the effects of immediate high-energy nutritional support versus gradual energy increase in patients with acute pancreatitis, focusing on p
Objective: To investigate the role of the pentose phosphate pathway (PPP) and circPLCE1 in fibroblast metabolism and intestinal fibrosis in Crohn's disease, hig
Objective: To diagnose the underlying cause of chronic diarrhea in a patient with significant weight loss and gastrointestinal symptoms, emphasizing the urgency
Objective: To analyze the clinical and molecular characteristics of CTNNA1 germline variants and their association with hereditary diffuse gastric cancer (HDGC)
CTNNA1 germline variants are linked to hereditary diffuse gastric cancer (HDGC), with truncating variants posing a moderate risk compared to CDH1 variants.
The study identifies the pathophysiological mechanism for CTNNA1-truncating variants, establishing them as key contributors to HDGC.
Clinical criteria for CTNNA1 genetic testing were proposed, enhancing the identification of individuals at risk for HDGC.
CTNNA1-truncating variants lead to increased likelihood of developing gastric cancer compared to wild-type individuals.
This research provides the largest dataset on CTNNA1-associated diseases, aiding in clinical management and variant classification.
Objective: To investigate the role of FOXM1 in epithelial disruption in eosinophilic esophagitis (EoE) and assess its potential as a therapeutic target, which m
Objective: To investigate the association of specific bacterial genomic structural variations (SVs) with autism spectrum disorder (ASD) and their potential as d
Objective: To investigate the role of Pirin (PIR) in mediating inflammation and its implications in hepatocellular carcinoma (HCC) progression, particularly foc
Pirin (PIR) is significantly upregulated in hepatocellular carcinoma (HCC) and translocates to the nucleus during disease progression.
PIR facilitates ROS-associated long-term inflammation through NF-κB1 and STAT3 pathways, creating a positive feedback loop that accelerates HCC development.
Inhibition of PIR may reduce liver inflammation and ROS production, suggesting it as a potential target for antitumor therapy in HCC.
Patients with high PIR expression have poorer overall survival rates, indicating its clinical relevance in HCC progression.
PIR's role in mediating the crosstalk between ROS and inflammation highlights its importance in the pathogenesis of HCC.
Objective: To investigate the interplay between hereditary chronic pancreatitis (CP) and mutant Kras in the initiation of pancreatic cancer using a humanised mo
Chronic pancreatitis significantly increases the risk of pancreatic cancer, with hereditary forms posing a 69-fold higher risk.
The study combined Cpa1N256K and KrasG12D mutations in a mouse model to explore the interaction between hereditary chronic pancreatitis and pancreatic cancer.
Distinct populations of acinar-to-ductal metaplasia were identified, revealing an inflammatory ductal phenotype unique to chronic pancreatitis.
Intercellular signaling networks involving various cell types were mapped, highlighting synergistic interactions between inflammation and oncogenic processes.
The new mouse model offers a more physiologically relevant system for studying chronic pancreatitis as a risk factor for pancreatic cancer.
Objective: To investigate the impact of chronic stress on gut microbiota and its role in promoting cancer metastasis. Key Findings: Chronic stress promotes canc
Objective: To investigate the role of Parasutterella excrementihominis in exacerbating experimental colitis and colitis-associated colorectal cancer through the
Objective: To investigate the role of indole-3-propionic acid (IPA) and tryptophan (Trp) metabolism in diabetic retinopathy (DR) and explore potential therapeut
Objective: To clarify the relationships among gut microbiome composition, diet, and the progression of chronic kidney disease (CKD), highlighting the significan
Objective: To investigate the therapeutic potential of a personalized low-glycemic diet (PLGD) in managing irritable bowel syndrome (IBS) and its impact on gluc
Objective: To share specific experiences and data from the Mayo Clinic on implementing a large panel liquid biopsy assay for comprehensive genomic profiling, in
Objective: To explore emerging frontiers in non-target screening across various fields and identify common challenges faced by researchers. Key Findings: Non-ta
Objective: To assess public comfort and perceptions regarding the use of AI in health care. Key Findings: Add: '20% reported using AI to prepare for an upcoming
Glaukos has secured a permanent HCPCS J-code (J2789) for its Epioxa therapy, which will simplify billing and reimbursement for its epithelium-on corneal cross-l
